Cargando…
Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines
In the present pilot study, we examined the presence of serglycin in lung, breast, prostate, and colon cancer and evaluated its expression in cell lines and tissues. We found that serglycin was expressed and constitutively secreted in culture medium in high levels in more aggressive cancer cells. It...
Autores principales: | Korpetinou, Angeliki, Papachristou, Dionysios J., Lampropoulou, Angeliki, Bouris, Panagiotis, Labropoulou, Vassiliki T., Noulas, Argyrios, Karamanos, Nikos K., Theocharis, Achilleas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637082/ https://www.ncbi.nlm.nih.gov/pubmed/26581653 http://dx.doi.org/10.1155/2015/690721 |
Ejemplares similares
-
Serglycin: At the Crossroad of Inflammation and Malignancy
por: Korpetinou, Angeliki, et al.
Publicado: (2014) -
Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells
por: Korpetinou, Angeliki, et al.
Publicado: (2013) -
Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential
por: Manou, Dimitra, et al.
Publicado: (2020) -
IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules
por: Afratis, Nikolaos A., et al.
Publicado: (2017) -
Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours
por: Labropoulou, Vassiliki T., et al.
Publicado: (2013)